Acumen Pharmaceuticals, Inc. (ABOS)
$2.14+1.90%Close
SELLCRISIS · day 20
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $155M
- Beta
- 0.33
- P/E (TTM)
- -1.24
- Short % float
- 5.57%
- Days to cover
- 4.8
- SI change
- +9.8%
- 1W
- +4.90%
- 1M
- -25.17%
- vs SPY 1W
- +3.74%
- vs SPY 1M
- -28.17%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ABOS?
- LOPJLB’s latest quantitative signal on Acumen Pharmaceuticals, Inc. (ABOS) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ABOS in?
- Acumen Pharmaceuticals, Inc. (ABOS) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Acumen Pharmaceuticals, Inc. (ABOS) do?
- Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the clinical development stage, dedicated to discovering and advancing therapeutic solutions for Alzheimer's disease. A key focus for the company involves progressing ACU193, an investigational targeted immunotherapy drug candidate. This particular humanized monoclonal antibody is currently undergoing initial human testing in…